Paradigm Capital Management Inc’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Paradigm Capital Management Inc’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-728,200	Closed	-$4.44M	–	164
2021 Q3	$4.44M	Buy	728,200 +628,200	+628%	+$3.92M	0.23%	82
2021 Q2	$823K	Buy	100,000 +90,000	+900%	+$765K	0.04%	125
2021 Q1	$89K	Buy	+10,000	New	+$115K	﹤0.01%	149
2020 Q4	–	Sell	-50,000	Closed	-$520K	–	161
2020 Q3	$520K	Hold	50,000	–	–	0.04%	124
2020 Q2	$657K	Hold	50,000	–	–	0.06%	113
2020 Q1	$393K	Buy	50,000 +40,000	+400%	+$602K	0.05%	124
2019 Q4	$207K	Hold	10,000	–	–	0.02%	145
2019 Q3	$137K	Hold	10,000	–	–	0.01%	153
2019 Q2	$123K	Buy	+10,000	New	+$115K	0.01%	156

Paradigm Capital Management Inc's FLXN Position: Q4 2021 in Review

Paradigm Capital Management Inc sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 728,200 shares — an estimated $4.44M sold.

Paradigm Capital Management Inc first reported a position in FLXN in Q2 2019 and held it in 9 quarters. The position peaked at $4.44M in Q3 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Paradigm Capital Management Inc reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Paradigm Capital Management Inc sold 728,200 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $4.44M.
Paradigm Capital Management Inc first reported a position in Flexion Therapeutics, Inc. in Q2 2019 and held it in 9 quarters.
Paradigm Capital Management Inc's Flexion Therapeutics, Inc. position peaked at $4.44M in Q3 2021.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Paradigm Capital Management Inc's 13F filing for Q4 2021, filed 9 Feb 2022.